# Celltrion USA signs $22M contract to supply Covid-19 tests to US

Celltrion USA has signed a $22 million contract to supply its SAMPINUT rapid antigen test kits to the US, following FDA Emergency Use Authorization.

- Type: Contract
- Announced: 2020-11-02
- Where: United States
- Value: $22.0M
- Status: announced
- Products: SAMPINUT rapid antigen test kit
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Celltrion USA](https://endata.com/companies/50913.md)

## Sources

- [medicaldevice-network.com](https://www.medicaldevice-network.com/uncategorized/54293/), 2020-11-02: "Celltrion USA has signed a contract to supply $22m worth of Covid-19 diagnostic tests to the US."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.